UK biotech investor Arix Bioscience is looking for a new CEO after Joe Anderson decided to focus on running the investment side of the business and a reshuffle of its board.
Novartis is aiming to draw a line under a scandal involving payments to Donald Trump's former lawyer with a new ethics chief - Siemens' former compliance head Klaus Moosmayer.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.